There are downsides to approving a drug in this way. The alsheimers community itself is divided on this question. It's possible that we're going to have this drug that overwhelms the us Health care system because it costs so much, and we're just going to be giving the patients who receive it false hope because it doesn't even work yet.
For decades, Alzheimer’s researchers have been stubbornly pursuing a single theory, but they’re starting to wonder: is this narrow focus the reason we still don’t have a cure?
For more, go to http://vox.com/unexplainable
It’s a great place to sign up for our newsletter, view show transcripts, and read more about the topics on our show.
Also, email us! unexplainable@vox.com
We read every email.
Support Unexplainable by making a financial contribution to Vox! bit.ly/givepodcasts
Learn more about your ad choices. Visit podcastchoices.com/adchoices